L-Flox IV Infusion (Levofloxacin Injection) 500mg

L-Flox IV Infusion is a prescription fluoroquinolone antibacterial agent containing Levofloxacin as its active ingredient. Administered intravenously, this 500mg strength injection is utilized to treat severe bacterial infections when oral therapy is not feasible or appropriate. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, essential enzymes required for bacterial DNA replication, transcription, repair, and recombination.

Strength

500mg

Pack Size

Storage

Ambient

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

L-Flox IV Infusion is indicated for the treatment of adults with mild, moderate, or severe infections caused by susceptible strains of designated microorganisms. Key clinical indications include community-acquired pneumonia, nosocomial pneumonia, complicated urinary tract infections, acute pyelonephritis, and complicated skin and skin structure infections.

Side Effects

Common side effects associated with L-Flox IV Infusion include nausea, headache, diarrhea, constipation, dizziness, and localized injection site reactions. Serious adverse reactions associated with fluoroquinolones include tendonitis, tendon rupture, peripheral neuropathy, central nervous system effects (such as convulsions or anxiety), and prolongation of the QT interval. Patients should contact their healthcare provider immediately if they experience joint pain, muscle weakness, tingling sensations, or severe skin rashes.

Precautions & Warnings

L-Flox IV Infusion should be used with caution in patients with known predisposing factors for seizures, renal impairment, or a history of tendon disorders. Dosage adjustments are required for patients with impaired renal function. This medication is classified under Pregnancy Category C and should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. Patients should avoid excessive sunlight or artificial UV exposure during treatment due to the risk of phototoxicity.

Avoid Interactions

Levofloxacin may interact with class IA or class III antiarrhythmic agents, potentially increasing the risk of QT interval prolongation. Concomitant administration with nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the risk of central nervous system stimulation and convulsive seizures. Systemic corticosteroids can elevate the risk of tendon rupture, and concurrent use of antidiabetic agents requires close monitoring of blood glucose levels due to the risk of hypoglycemia or hyperglycemia.

Frequently Asked Questions

L-Flox IV Infusion is prescribed for the treatment of moderate to severe bacterial infections, including community-acquired pneumonia, nosocomial pneumonia, complicated urinary tract infections, acute pyelonephritis, and complicated skin infections.

L-Flox IV Infusion is administered as a slow intravenous infusion by a qualified healthcare professional in a clinical setting. It is not intended for self-administration.

Levofloxacin, like other fluoroquinolones, carries warnings regarding the risk of tendonitis, tendon rupture, peripheral neuropathy, central nervous system effects, and the exacerbation of muscle weakness in patients with myasthenia gravis.

L-Flox IV Infusion is classified as Pregnancy Category C. It should only be used during pregnancy if the potential therapeutic benefit to the mother outweighs the potential risks to the developing fetus, as determined by a medical professional.

Yes, Levofloxacin can interact with several drugs, including certain antiarrhythmics, NSAIDs, systemic corticosteroids, and antidiabetic medications. Always inform your healthcare provider of all medications you are currently taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.